Search Results 101-110 of 17252 for protein intake optimization

1. Orthopedic Surgery Clinical Trials - Medical Professionals

   This study is being conducted to determine gene and protein ... This will provide real-world data and evidence in optimizing care for spinal deformity patients.

2. Bariatric Surgery Clinical Trials - Mayo Clinic Research

   Though nicotine is known to be a mild analgesic, its use in the peri-operative period to reduce postoperative opioid requirements has only recently been ...

3. A Study Comparing Gemcitabine with or without AZD 1775 in Treating Patients with Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... AZD 1775 may block specific protein activity and ... requirements. Participating Mayo Clinic ...

4. Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... protein in the beta region, may be considered ... * Active renal condition (infection, requirement for dialysis ...

5. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Urine protein to creatinine ratio (UPC) < 1; NOTE ... requirement for steroids or anti-seizure ...

6. Study of bb2121 in Multiple Myeloma - Clinical Trials

   ... optimal dosages and risks/benefits. In the later ... Serum M-protein greater or equal to 0.5 g/dL; ... Are experiencing continued symptoms from their venous ...

7. irritable bowel syndrome Archives - Mayo Clinic News Network

   an appropriate evaluation of your symptoms and provide treatments to help you optimize your ... intake and consider raising the head of the bed ... protein) linked ...

8. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... JCAR017 is a CAR-T therapy directed against CD19 (a cell surface protein ... Subject is willing and able to ...

9. Acetylsalicylic Acid in Preventing Disease Recurrence in Patients With Barrett's Esophagus After Successful Elimination by Radiofrequency Ablation - Mayo Clinic

   ... optimal dosages and risks/benefits. In the later ... Studying samples of tissue from patients with Barrett's esophagus for the levels of a specific protein ...

10. First In Human (FIH) Study of REGN5459 in Patients With Relapsed or Refractory Multiple Myeloma (MM) - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... protein may be enrolled if quantitative IgA ... requirement. 3. Hemoglobin > 8.0 g/dL - Adequate ...